Table 1 Patient characteristics
|  | Overall | Albumin ≥ 4.0 | Albumin < 4.0 | P value |
|---|---|---|---|---|
Number of patients | 56 | 36 | 20 | Â |
Age (year) | Â | Â | Â | 0.6563 |
Median (range) | 55 (23–70) | 52 (23–70) | 56 (28–68) |  |
ECOG performance status score – no. (%) | 0.0877 | |||
0 -1 | 48 (86) | 33 | 15 | Â |
2- | 8 (14) | 3 | 5 | Â |
Histological diagnosis – no. (%) |  |  |  | 0.2583 |
Serous cystadenocarcinoma | 37 (66) | 25 | 12 | Â |
Endometrioid adenocarcinoma | 6 (11) | 5 | 1 | Â |
Clear cell adenocarcinoma | 5 (8.9) | 2 | 3 | Â |
Others | 4 (7.1) | 3 | 1 | Â |
Unknown | 4 (7.1) | 1 | 3 | Â |
Site of metastasis – no. (%) |  |  |  |  |
Peritoneum | 29 (52) | 20 | 9 | 0.1413 |
Liver | 11 (20) | 7 | 4 | 0.5185 |
Ascites | 21 (38) | 13 | 8 | 0.4371 |
Peptide | Â | Â | Â | 0.1694 |
WT1 | 46 (82) | 31 | 15 | Â |
MUC1 | 39 (70) | 27 | 12 | Â |
CA125 | 16 (29) | 7 | 9 | Â |
Number of DC vaccine administration | ||||
Median (range) | 7 (5–20) | 7 (5–18) | 7 (5–20) | 0.6867 |